Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer DOI Creative Commons
Yunfang Yu, Wenda Zhang,

Anlin Li

et al.

JAMA Network Open, Journal Year: 2020, Volume and Issue: 3(4), P. e202149 - e202149

Published: April 7, 2020

Importance

Long noncoding RNAs (lncRNAs) are involved in innate and adaptive immunity cancer by mediating the functional state of immunologic cells, pathways, genes. However, whether lncRNAs associated with immune molecular classification clinical outcomes immunotherapy is largely unknown.

Objectives

To explore lncRNA-based subtypes survival response to present a novel lncRNA score for prediction using computational algorithms.

Design, Setting, Participants

In this cohort study, an individual patient analysis based on phase 2, single-arm trial multicohort was performed from June 25 through September 30, 2019. Data 2 IMvigor210 The Cancer Genome Atlas (TCGA). study analyzed genomic data 348 patients bladder 71 melanoma TCGA who were treated immunotherapy. addition, pancancer that included 2951 obtained TCGA.

Main Outcomes Measures

primary end point overall (OS).

Results

Among (272 [78.2%] male) (mean [SD] age, 58.3 [13.4] years; 37 [52.1%] female), 4 distinct classes statistically significant differences OS (median months, not reached vs 9.6 8.1 6.7 months;P = .002) identified. greatest benefit immune-active class, as characterized immune-functional signature high CTL infiltration. Patients low scores had significantly longer (hazard ratio, 0.32; 95% CI, 0.24-0.42;P < .001) across various types. immunotherapeutic (area under curve [AUC], 0.79 at 12 months 0.77 20 months) (AUC, 0.87 24 months), superior tumor alteration burden, programmed cell death ligand 1 (PD-L1) expression, cytotoxic T-lymphocyte (CTL) Addition combination PD-L1 infiltration build multiomics algorithm correlated more strongly 0.81 0.80 months).

Conclusions Relevance

This identifies recommends class. should be integrated into multiomic panels precision

Language: Английский

Best practices for bioinformatic characterization of neoantigens for clinical utility DOI Creative Commons
Megan M. Richters, Huiming Xia, Katie M. Campbell

et al.

Genome Medicine, Journal Year: 2019, Volume and Issue: 11(1)

Published: Aug. 28, 2019

Neoantigens are newly formed peptides created from somatic mutations that capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens create personalized immunotherapies for cancer treatment. To a vaccine, must be computationally predicted matched tumor-normal data, then ranked according their capability in stimulating response. This candidate neoantigen prediction process involves multiple steps, including mutation identification, HLA typing, peptide processing, peptide-MHC binding prediction. The general workflow has been utilized many preclinical clinical trials, but there is no current consensus approach few established best practices. In this article, we review recent discoveries, summarize the available computational tools, provide analysis considerations each step, prediction, prioritization, delivery, validation methods. addition reviewing state analysis, practical guidance, specific recommendations, extensive discussion critical concepts points confusion practice characterization use. Finally, outline necessary areas development, need improve class II typing accuracy, expand software support diverse sources, incorporate response data algorithms. ultimate goal workflows vaccines patient outcomes types.

Language: Английский

Citations

176

m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer DOI Creative Commons
Wei Chong, Liang Shang, Jin Liu

et al.

Theranostics, Journal Year: 2020, Volume and Issue: 11(5), P. 2201 - 2217

Published: Dec. 16, 2020

Recent studies have highlighted the biological significance of RNA N6-methyladenosine (m6A) modification in tumorigenicity and progression. However, it remains unclear whether m6A modifications also potential roles immune regulation tumor microenvironment (TME) formation. Methods: In this study, we curated 23 regulators performed consensus molecular subtyping with NMF algorithm to determine patterns m6A-related gene signature colon cancer (CC). The ssGSEA CIBERSORT algorithms were employed quantify relative infiltration levels various cell subsets. An PCA based m6Sig scoring scheme was used evaluate individual tumors an response. Results: Three distinct identified among 1307 CC samples, which associated different clinical outcomes pathways. TME characterization revealed that highly consistent three known profiles: immune-inflamed, immune-excluded, immune-desert, respectively. Based on score, extracted from genes, patients can be divided into high low score subgroups. Patients lower characterized by prolonged survival time enhanced infiltration. Further analysis indicated correlated greater mutation loads, PD-L1 expression, higher rates SMGs (e.g., PIK3CA SMAD4). addition, scores showed a better responses durable benefits independent immunotherapy cohorts. Conclusions: This study highlights is significantly diversity complexity. Quantitatively evaluating will strengthen our understanding characteristics promote more effective strategies.

Language: Английский

Citations

176

Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq DOI
Christina Plattner, Francesca Finotello, Dietmar Rieder

et al.

Methods in enzymology on CD-ROM/Methods in enzymology, Journal Year: 2019, Volume and Issue: unknown, P. 261 - 285

Published: June 22, 2019

Language: Английский

Citations

172

Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma DOI Creative Commons
Shuguang Zuo, Min Wei, Shiqun Wang

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: June 30, 2020

Background: The tumor microenvironment (TME) consists of heterogeneous cell populations, including malignant cells and nonmalignant that support proliferation, invasion, metastasis through extensive crosstalk. intra-tumor immune landscape is a critical factor influencing patient survival response to immunotherapy. Methods: Gene expression data were downloaded from Cancer Genome Atlas Expression Omnibus databases. Immune infiltration was determined by single-sample gene set enrichment analysis (ssGSEA) depending on the integrated sets published studies. Univariate used determine prognostic value infiltrated cells. LASSO regression performed screen for most survival-relevant An immune-cell characteristic score (ICCS) model constructed using multivariate Cox analysis. Results: patterns across 32 cancer types identified, patients in high cluster had worse overall (OS) but better progression-free interval (PFI) compared low cluster. However, showed inconsistent type. High indicated prognosis LGG, GBM, UVM, favorable ACC, CESE, CHOL, HNSC, LIHC, LUAD, SARC, SKCM. LUAD significantly influenced 13 types, with all Th2 correlating prognosis. ICCS based 6 populations generated classified into low- high-ICCS groups good poor respectively. stratified further revealed an independent LUAD. Conclusions: quantified considerable heterogeneity observed relevance these different types. competent performance, which can deepen our understanding lung adenocarcinoma have implications

Language: Английский

Citations

161

Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods DOI Open Access
Alejandro Jiménez-Sánchez, Oliver Cast, Martin L. Miller

et al.

Cancer Research, Journal Year: 2019, Volume and Issue: 79(24), P. 6238 - 6246

Published: Oct. 22, 2019

Various computational approaches have been developed for estimating the relative abundance of different cell types in tumor microenvironment (TME) using bulk RNA data. However, a comprehensive comparison across diverse datasets that objectively evaluates performance these has not conducted. Here, we benchmarked seven widely used tools and gene sets introduced Consensus

Language: Английский

Citations

160

Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer DOI
Meng Zhou, Zicheng Zhang, Siqi Bao

et al.

Briefings in Bioinformatics, Journal Year: 2020, Volume and Issue: 22(3)

Published: March 9, 2020

Abstract Long noncoding RNAs (lncRNAs) have been associated with cancer immunity regulation and the tumor microenvironment (TME). However, functions of lncRNAs tumor-infiltrating B lymphocytes (TIL-Bs) their clinical significance not yet fully elucidated. In present study, a machine learning-based computational framework is presented for identification lncRNA signature TIL-Bs (named ‘TILBlncSig’) through integrative analysis immune, profiles. The TILBlncSig comprising eight (TNRC6C-AS1, WASIR2, GUSBP11, OGFRP1, AC090515.2, PART1, MAFG-DT LINC01184) was identified from list 141 B-cell-specific lncRNAs. capable distinguishing worse compared improved survival outcomes across different independent patient datasets also other covariates. Functional characterization revealed it to be an indicator infiltration mononuclear immune cells (i.e. natural killer cells, B-cells mast cells), hallmarks cancer, as well immunosuppressive phenotype. Furthermore, predictive value outcome immunotherapy response patients anti-programmed death-1 (PD-1) therapy added significant power current checkpoint gene markers. study has highlighted cell in TME RNA perspective strengthened potential application biomarkers response, which warrants further investigation.

Language: Английский

Citations

152

Next-generation computational tools for interrogating cancer immunity DOI
Francesca Finotello, Dietmar Rieder, Hubert Hackl

et al.

Nature Reviews Genetics, Journal Year: 2019, Volume and Issue: 20(12), P. 724 - 746

Published: Sept. 12, 2019

Language: Английский

Citations

147

Applications of single-cell and bulk RNA sequencing in onco-immunology DOI Creative Commons
M. Kuksin, Daphné Morel, Marine Aglave

et al.

European Journal of Cancer, Journal Year: 2021, Volume and Issue: 149, P. 193 - 210

Published: April 16, 2021

The rising interest for precise characterization of the tumour immune contexture has recently brought forward high potential RNA sequencing (RNA-seq) in identifying molecular mechanisms engaged response to immunotherapy. In this review, we provide an overview major principles single-cell and conventional (bulk) RNA-seq applied onco-immunology. We describe standard preprocessing statistical analyses data obtained from such techniques highlight some computational challenges relative individual cells. notably examples gene expression as differential analysis, dimensionality reduction, clustering enrichment analysis. Additionally, used public sets exemplify how deconvolution algorithms can identify quantify multiple subpopulations either bulk or RNA-seq. give machine deep learning models predict patient outcomes treatment effect high-dimensional data. Finally, balance strengths weaknesses regarding their applications clinic.

Language: Английский

Citations

109

Innate Immunity and Cancer Pathophysiology DOI Open Access
Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun

et al.

Annual Review of Pathology Mechanisms of Disease, Journal Year: 2021, Volume and Issue: 17(1), P. 425 - 457

Published: Nov. 18, 2021

Chronic inflammation increases the risk of several cancers, including gastric, colon, and hepatic cancers. Conversely, tumors, similar to tissue injury, trigger an inflammatory response coordinated by innate immune system. Cellular molecular mediators modulate tumor growth directly influencing adaptive response. Depending on balance cell types signals within microenvironment, can support or restrain tumor. Adding complexity, research from past two decades has revealed that cells are highly heterogeneous plastic, with variable phenotypes depending type, stage, treatment. The field is now cusp being able harness this wealth data (

Language: Английский

Citations

107

Neutrophil Heterogeneity in Cancer: From Biology to Therapies DOI Creative Commons
Pacôme Lecot, Matthieu Sarabi, Manuela Pereira-Abrantes

et al.

Frontiers in Immunology, Journal Year: 2019, Volume and Issue: 10

Published: Sept. 20, 2019

Neutrophils have been extensively described in the pathophysiology of autoimmune and infectious diseases. Accumulating evidence also suggests important role neutrophils cancer progression through their interaction with immune cells blood tumor microenvironment (TME). Most studies as key drivers progression, due to involvement various promoting functions including proliferation, aggressiveness dissemination, well suppression. However, such were focusing on late-stages tumorigenesis, which chronic inflammation had already developed. The tumor-associated (TANs) at early stages development remains poorly described, though recent findings indicate that early-stage TANs may display anti-tumor properties. Beyond site, supported by NLR retrospective functional analyses suggest could actively contribute tumorigenesis. Hence, it appears phenotype vary greatly during highlighting heterogeneity. origin pro- or is generally believed arise following a change cell state, from resting activated. Moreover, fate involve distinct differentiation programs yielding subsets pro neutrophils. In this review, we will discuss current knowledge heterogeneity across different tissues impact neutrophil-based therapeutic strategies shown promising results pre-clinical studies, paving way for design next generation immunotherapy.

Language: Английский

Citations

137